Skip to main content Skip to main navigation menu Skip to site footer

Predictors of Mortality for Critically Ill COVID-19 Patients: Systematic Review


Objective: To identify mortality predictors of critically ill COVID-19 patients in ICU based on current available literatures.

Methods: Systematic literature search was conducted in open-access databases. Data extraction was conducted for publication date, methodology employed, sample size, and results of multivariate analysis. Eligibility criteria for analysis was observational analytic design, sample size of 100 or more, and availability of multivariate results. Primary measures assessed was risk ratio, presented as odds ratio or hazard ratio. Data was analyzed qualitatively for themes that emerged for mortality predictors.

Results: Several mortality predictors were identified, which included demographic, clinical history, laboratory results, and oxygenation profile at ICU admission. Several of the most consistently reported mortality predictors was older age, one or more comorbidities that constitute metabolic syndrome, chronic pulmonary disorder, low lymphocyte and platelet count, elevated d-dimer, and low PaO2/FiO2 ratio.

Conclusions: Mortality predictors identified in this review were similar to previously known mortality and severity predictors of COVID-19 patients in general. This consistency may point to the potential of developing a scoring system to predict COVID-19 severity and mortality for clinical practice use.



  1. World Health Organization. COVID-19 Weekly Epidemiological Update. Geneva; 2021.
  2. COVID?19 Response Acceleration Task Force. Distribution Maps (Indonesian) [Internet]. 2020 [cited 2021 Jan 31]. Available from:
  3. Wirawan GBS, Januraga PP. Correlation of Demographic, Health Care Availability, And COVID-19 Outcome: Indonesian Ecological Study. Front Public Heal. 2021;9(605290).
  4. Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669–77.
  5. Abate SM, Ali SA, Mantfardo B, Basu B. Rate of intensive care unit admission and outcomes among patients with coronavirus: A systematic review and Meta-analysis. PLoS One [Internet]. 2020;15(7 July):1–19. Available from:
  6. Wirawan A, Januraga PP. Forecasting COVID-19 Transmission and Healthcare Capacity in Bali, Indonesia. J Prev Med Public Heal. 2020;53(3):158–63.
  7. Setiati S, Azwar MK. Dilemma of Prioritising Health and the Economy During COVID-19 Pandemic in Indonesia. Acta Med Indones. 2020;52(3):196–8.
  8. Maves RC, Downar J, Dichter JR, Hick JL, Devereaux A, Geiling JA, et al. Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Allocation: An Expert Panel Report of the Task Force for Mass Critical Care and the American College of Chest Physicians. Chest. 2020;158(1):212–25.
  9. Mudatsir M, Wulandari L, Fajar JK, Soegiarto G, Ilmawan M, Purnamasari Y, et al. Predictors of COVID-19 severity: A systematic review and meta-analysis. F1000Research. 2020;9:1–24.
  10. Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: A literature review. Rev Med Virol. 2020;(May).
  11. Ayed M, Borahmah AA, Yazdani A, Sultan A, Mossad A, Rawdhan H. Assessment of clinical characteristics and mortality-associated factors in COVID-19 Critical cases in Kuwait. Med Princ Pract. 2020;
  12. Biran N, Ip A, Ahn J, Go RC, Wang S, Mathura S, et al. Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study. Lancet Rheumatol [Internet]. 2020;2(10):e603–12. Available from:
  13. Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet [Internet]. 2020;395(10239):1763–70. Available from:
  14. Wendel Garcia PD, Fumeaux T, Guerci P, Heuberger DM, Montomoli J, Roche-Campo F, et al. Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort. EClinicalMedicine [Internet]. 2020;25:100449. Available from:
  15. Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk Factors Associated with Mortality among Patients with COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345–55.
  16. Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, et al. Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the US. JAMA Intern Med. 2020;02115(11):1436–46.
  17. Haase N, Plovsing R, Christensen S, Poulsen LM, Brøchner AC, Rasmussen BS, et al. Characteristics, interventions, and longer term outcomes of COVID-19 ICU patients in Denmark—A nationwide, observational study. Acta Anaesthesiol Scand. 2020;(August):1–8.
  18. Lu X, Jiang L, Chen T, Wang Y, Zhang B, Hong Y, et al. Continuously available ratio of SpO2/FiO2serves as a noninvasive prognostic marker for intensive care patients with COVID-19. Respir Res. 2020;21(1):1–4.
  19. Xu J, Yang X, Yang L, Zou X, Wang Y, Wu Y, et al. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: A multicenter retrospective study from Wuhan, China. Crit Care. 2020;24(1):1–11.
  20. Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. Int J Infect Dis [Internet]. 2020;101:138–48. Available from:
  21. Mesas AE, Cavero-Redondo I, Álvarez-Bueno C, Cabrera MAS, de Andrade SM, Sequí-Dominguez I, et al. Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions. PLoS One. 2020;15(11 November):1–23.
  22. Castelli V, Cimini A, Ferri C. Cytokine Storm in COVID-19: “When You Come Out of the Storm, You Won’t Be the Same Person Who Walked in.” Vol. 11, Frontiers in Immunology. 2020.
  23. de la Rica R, Borges M, Gonzalez-Freire M. COVID-19: In the Eye of the Cytokine Storm. Vol. 11, Frontiers in Immunology. 2020.
  24. Riva G, Nasillo V, Tagliafico E, Trenti T, Comoli P, Luppi M. COVID-19: More than a cytokine storm. Crit Care. 2020;24(1):10–2.
  25. Price LC, McCabe C, Garfield B, Wort SJ. Thrombosis and COVID-19 pneumonia: The clot thickens! Eur Respir J. 2020;56(1).
  26. Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Takeshita J, et al. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries. J Am Acad Dermatol. 2020;83(2):486–92.
  27. Malas MB, Naazie IN, Elsayed N, Mathlouthi A, Marmor R, Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine [Internet]. 2020;29–30:100639. Available from:
  28. Sprung CL, Joynt GM, Christian MD, Truog RD, Rello J, Nates JL. Adult ICU Triage during the Coronavirus Disease 2019 Pandemic: Who Will Live and Who Will Die? Recommendations to Improve Survival?. Crit Care Med. 2020;48(8):1196–202.
  29. Shang Y, Liu T, Wei Y, Li J, Shao L, Liu M, et al. Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine [Internet]. 2020;24(December 2019):100426. Available from:

How to Cite

Lusyana, L., Ariady, R. R., & Wirawan, G. B. S. (2021). Predictors of Mortality for Critically Ill COVID-19 Patients: Systematic Review. Intisari Sains Medis, 12(3), 794–800.




Search Panel

Lya Lusyana
Google Scholar
ISM Journal

Randika Rea Ariady
Google Scholar
ISM Journal

Gede Benny Setia Wirawan
Google Scholar
ISM Journal